Pharma Focus Asia is not the first publication to recognize Lvov's pioneering work in nanoencapsulation and drug reformulation. He has had over 160 papers on the topic published in peer-reviewed journals and, last November, was named the 2007 Innovator of the Year by Small Times Magazine for his work in this area.
But Lvov is quick to point out that he is not alone in this endeavor.
"This is not singular research. Drs. Mark DeCoster, David Mills, Patrick O'Neal and many Ph.D. students at the Institute for Micromanufacturing are diligently working on different parts of our drug nanoencapsulation program."
"Dr. Lvov's accomplishments contribute greatly to Louisiana Tech's international stature in the nanotechnology field," says Dr. Leslie Guice, vice president for research and development at Louisiana Tech. "He is highly respected among the research community and has built strong collaborations with top-notch researchers nationally and internationally."
In addition to the medical benefits of this research, there could also be a significant economic benefit for northern Louisiana.
"Nanoencapsulation research is of significant interest to pharmaceutical companies," explains Guice. "This could play an important role in helping us attract some of these companies to Louisiana."
"We (Louisiana Tech) are not making a new drug," explains Lvov. "But just as important, we are the engineers working in nanotechnology to make new, more efficient formulations for existing drugs."
The strength and success of this program will continue to be built upon the collaboration of Louisiana Tech researchers with those of other institutions.
"We hope that the partnerships Dr. Lvov has developed with other institutions will continue to produce significant advances in medicine and in basic science," says Napper.
Lvov believes there is another important benefi
'/>"/>
| Contact: Dave Guerin dguerin@latech.edu 318-257-4854 Louisiana Tech University Source:Eurekalert |